0000899243-22-019827.txt : 20220526
0000899243-22-019827.hdr.sgml : 20220526
20220526200832
ACCESSION NUMBER: 0000899243-22-019827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220524
FILED AS OF DATE: 20220526
DATE AS OF CHANGE: 20220526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARMAR KUSH
CENTRAL INDEX KEY: 0001664281
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40693
FILM NUMBER: 22972228
MAIL ADDRESS:
STREET 1: C/O AUDENTES THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY ST., SUITE 2650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rallybio Corp
CENTRAL INDEX KEY: 0001739410
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851083789
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203- 859-3820
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Rallybio Holdings, LLC
DATE OF NAME CHANGE: 20180502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-24
0
0001739410
Rallybio Corp
RLYB
0001664281
PARMAR KUSH
C/O RALLYBIO CORPORATION
234 CHURCH STREET, SUITE 1020
NEW HAVEN
CT
06510
1
0
0
0
Option (Right to Buy)
12.75
2022-05-24
4
A
0
13440
0.00
A
2032-05-24
Common Stock
13440
13440
D
The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders.
By:/s/ Michael Greco, Attorney-in-Fact
2022-05-26